Professor Anna Gavin aims to improve care for breast cancer patients by documenting the impact of the COVID-19 pandemic on their care and identifying areas where improvements can be made now and in the future.

Professor Qing-Jun Meng is investigating how the inner clock in breast cancer cells is involved in the disease. This could lead to new treatments as well as improve existing ones.

Professor Ian Kunkler is investigating the impact that an additional, targeted booster dose of radiotherapy has on preventing DCIS from returning and developing into invasive breast cancer, and the effects it has on breast appearance and quality of life.

Dr Niamh Buckley is working to develop a treatment for triple negative breast cancer, using technology similar to that used in the COVID-19 vaccine.

Dr Timothy Humphrey is studying DNA modifications present in breast cancers, which could play a role in helping tumours to grow. His work could lead to new ways of treating breast cancers and ultimately save lives. 

Dr Ross Chapman is investigating the potential of drugs called PLK inhibitors to treat breast cancer with a genetic change that is found in around 10% of cases.